Angiotensin II-mediated vascular smooth muscle cell growth signaling

Brazilian Journal of Medical and Biological Research

Volumn 33, Issue 6, 2000, Pages 619-624

  Inagami, T ^a   Eguchi, S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Epidermal growth factor receptor; Type 1 receptor; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN II; CALCIUM; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE;

ANIMAL; CELL CULTURE; CELL DIVISION; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RAT; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; CALCIUM; CELL DIVISION; CELLS, CULTURED; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTEIN KINASES; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

EID: 0034202880     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2000000600002     Document Type: Article

References (32)

1. Geisterfer AA, Peach MJ & Owens GK (1988). Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circulation Research, 62: 749-756.
2. Gibbons GH, Pratt RE & Dzau VJ (1992). Vascular smooth muscle cell hypertrophy vs hyperplasia of cultured rat aortic smooth muscle cells. Journal of Clinical Investigation, 90: 456-461.
3. Weber H, Taylor DS & Molloy CJ (1994). Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells: correlation with the expression of specific endogenous growth factors and reversal by suramin. Journal of Clinical Investigation, 93: 788-798.
4. 1 receptor subtype. Circulation Research, 73: 413-423.
5. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC & Baker KM (1993). Angiotensin II is mitogenic in neonatal rat cardiac fibroblast. Circulation Research, 72: 1245-1254.
6. Griendling KK, Ushio FM, Lassegue B & Alexander RW (1997). Angiotensin II signaling in vascular smooth muscle: new concepts. Hypertension, 29: 366-373.
7. Berk BC & Corson MA (1997). Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circulation Research, 80: 607-626.
8. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benefield P, Carini DJ, Lee RJ, Wexler RR, Save JAM & Smith RD (1993). Angiotensin II receptors and angiotensin II receptor antagonist. Pharmacological Reviews, 45: 205-251.
9. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hassegawa M, Matsuda Y & Inagami T (1991). Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor Nature, 351: 230-233.
10. Murphy TJ, Alexander RW, Griendling KK, Runge MS & Bernstein KE (1991). Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature, 351: 233-236.
11. 1 receptor. Nature, 375: 247-255.
12. 1 receptor. Journal of Biological Chemistry, 272: 23382-23388.
13. 1 receptor. Journal of Biological Chemistry, 273: 7703-7708.
14. Dostal DE, Hunt RA, Kule CE, Bhat GJ, Karoor V, McWhinney CD & Baker KM (1997). Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways. Journal of Molecular and Cellular Cardiology, 29: 2893-2902.
15. 2+/calmodulin sensitive tyrosine kinase. Journal of Biological Chemistry, 271: 14169-14175.
16. Zhou Y, Komuro I, Yamazaki T, Kudoh S, Aikawa R, Zhu W, Shiojima I, Hiroi Y, Tobe K, Kadowaki T & Yazaki Y (1998). Cell type specific angiotensm II-evoked signal transduction pathways. Circulation Research, 82: 337-345.
17. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KN, Hirata Y, Murumo F & Inagami T (1998). Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Journal of Biological Chemistry, 273: 8890-8896.
18. Levitzki A & Gazit A (1995). Tyrosine kinase inhibition: an approach to drug development. Science, 267: 1782-1788.
19. Zwick E, Hackel PO, Norbert P & Ullrich A (1999). The EGF receptor as central transducer of heterologous signaling systems. Trends in Pharmacological Sciences, 20: 408-412.
20. Carpenter G (1999). Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways. Journal of Cell Biology, 146: 697-702.
21. Luttrell LM, Kaaka Y & Lefkowitz RJ (1999). Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Current Opinion in Cell Biology, 11: 177-183.
22. Sasaki H, Nagura K, Ishino M, Tobioka H, Kotani K & Sasaki T (1995). Cloning and characterization of cell adhesion kinase ß, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. Journal of Biological Chemistry, 270: 21206-21219.
23. 2+-induced regulation of ion channel and MAP kinase functions. Nature, 376: 737-745.
24. Avaham S, London R, Fu Y, Ota S, Hiregowdara D, Li J, Jiang S, Pasztor LM, White RA, Groopman JE & Avaham H (1995). Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. Journal of Biological Chemistry, 270: 27742-27751.
25. Yu H, Li X, Marchetto GS, By R, Hunter D, Calvo B, Dawson TL, Wilm M, Anderegg RJ, Graves LM & Earp HS (1996). Activation of a novel calcium-dependent protein-tyrosine kinase: correlation with c-Jun N-terminal kinase but not mitogen activated protein kinase activation. Journal of Biological Chemistry, 271: 29993-29998.
26. Eguchi S, Iwasaki H, Inagami T, Numaguchi K, Yamakawa T, Motley ED, Owada KM, Marumo F & Hirata Y (1999). Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells. Hypertension, 33 (Part II): 201-206.
27. Brinson AE, Harding T, Diliberto PA, He Y, Li X, Hunter D, Herman B, Earp HS & Graves LM (1998). Regulation of a calcium-dependent tyrosine kinase in vascular smooth muscle cells by angiotensin II and platelet-derived growth factor: dependence on calcium and the actin cytoskeleton. Journal of Biological Chemistry, 273: 1711-1718.
28. Murasawa S, Mori Y, Nozawa Y, Masaki H, Maruyama K, Tustsumi Y, Moriguchi Y, Shibasaki Y, Tanaka Y, Iwasaka T, Inada M & Matsubara H (1998). Role of calcium-sensitive tyrosine kinase PYK2/CAKß/ RAFTK in angiotensin II-induced Ras/ERK signaling. Hypertension. 32: 668-675.
29. Dikic I, Tokiwa G, Lev S, Courteneige SA & Schlessinger J (1996). A role for Pyk 2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature, 383: 547-550.
30. Eguchi S, Iwasaki H, Hirata Y, Frank GD, Motley ED, Yamakawa T, Numaguchi K & Inagami T (1999). Epidermal growth factor receptor is indispensable for c-Fos expression and protein synthesis by angiotensin II. European Journal of Pharmacology, 376: 203-206.
31. Eguchi S, Iwasaki H, Ueno H, Frank GD, Motley ED, Eguchi K, Marumo F, Hirata Y & Inagami T (2000). Possible requirement of EGF receptor, RAS, ERK and AKT. Journal of Biological Chemistry (in press).
32. Alessi DR & Cohen P (1998). Mechanism of activation and function of protein kinase B. Current Opinion in Genetics and Development, 8: 55-62.